We then investigated the effects of ADCC mediated by DB against GD2-positive NB cells on the expression of CD226, TIGIT and PD-1 by NK cells, and on the expression of CD112, CD155 and PD-L1 by tumor cells. The gene discussed is CD226; the disease is neuroblastoma.